Accenture 2016 Consumer Survey on Patient …...Title Accenture 2016 Consumer Survey on Patient...

Accenture 2016

Consumer Survey on

Patient Engagement

Global Report

Copyright © 2016 Accenture. All rights reserved. 2

• Accenture commissioned a seven-country survey of 7,840 consumers ages

18+ to assess their attitudes toward health, the healthcare system, electronic

health records, healthcare technology and their healthcare providers’

electronic capabilities.

• The online survey included consumers across seven countries: Australia (1013),

Brazil (1006), England (1009), Norway (800), Saudi Arabia (852), Singapore

(935) and the United States (2225).

• The seven-country survey was conducted by Nielsen on behalf of Accenture

between November 2015 and January 2016 (The US survey was conducted

online between November 13 and December 2, 2015).

• The analysis provided comparisons by country, sector, age and use.

• Where relevant, the survey uses select findings from the 2015 Accenture

Doctors Survey to compare the doctor and consumer responses.

Overview


Method

With whom did Accenture work to conduct the

quantitative survey?

Accenture worked with Nielsen, who was responsible for the

entire project including recruitment, screening of respondents,

questionnaire development, analysis and report development.

Who was surveyed?

Approximately, n=7840 consumers total, ages 18+, in the US,

Australia, Brazil, England, Norway, Saudi Arabia, and Singapore

who agreed to take part in the survey.

How did Accenture recruit study participants?

Respondents were contacted through direct email invitations and

notifications; respondents are able to follow a unique link to the

survey and complete it anonymously.

Are we confident in the quality of the respondents and that they

meet the study criteria?

All participants are consumers, ages 18+, residing in the countries

specified and nationally representative on age and gender.

Participants’ details are double verified and were rescreened for

this study to ensure participant quality.

Was the questionnaire translated into the appropriate native

language?

Yes, the survey was translated into: Portuguese (Brazil);

Norwegian (Norway); Arabic (Saudi Arabia). English (localized)

was used for England, Australia, Singapore, and Saudi Arabia

(English and Arabic options offered).

What did we do to ensure balance and a

representative sample?

Data were weighted to be nationally representative of the general

population in each country (or the online population in the case

of Brazil*).

• In Australia, data were weighted by education, age by sex,

region, and income

• In Brazil, data were weighted by sex, age, region, income

socioeconomic group, internet connection type, and

whether an online buyer

• In England, data were weighted by region, education, age

by sex, and hours online

• In Norway, data were weighted by age by gender,

education, income, region, and household size

• In Saudi Arabia, data were weighted by age by sex,

nationality, and region

• In Singapore, data were weighted by age by sex, ethnicity,

and household income

• In the US, data were weighted by education, age by sex,

race/ethnicity, region, and income to be nationally

representative of the general population. However, because

2014 data were not weighted, all data for trended questions

are not weighted. This is indicated on each slide.

*Brazil weighted to online population because the internet penetration is still relatively

low and with online sample you cannot reach a sufficiently representative sample for

general population representation.

4

Research Results:

Key Findings


Most consumers with EHRs have not accessed their

records

BASE: HAS EHR: Global 2016 n=5408;Australia 2014 n=764,2016 n=657; Brazil 2014 n=804,2016 n=647; England 2014 n=811,2016 n=677;

Norway 2014 n=669,2016 n=632; Saudi Arabia 2016 n=544; Singapore 2014 n=617,2016 n=597; US 2014 n=1585,2016 n=1654;

Q820. (Q158.) Have you ever accessed your electronic health records?

NOTE: unweighted data

Have Ever Accessed EHR

70%

86% 86%

56%

67%

91% 87% 87%

75%69% 73% 75% 73%

55%

30%

14% 14%

44%

33%

9% 13% 13%

25%31% 27% 25% 27%

45%

2015 2014 2015 2014 2015 2014 2015 2014 2015 2015 2014 2015 2014 2015

No Yes

Global Australia Brazil England Norway Saudi Arabia Singapore US


Among consumers with EHRs, lab work and

prescription history are most commonly available

BASE: HAS EHR : Global 2016 n=5408;Australia 2014 n=1020,2016 n=657; Brazil 2014 n=1015,2016 n=647; England 2014 n=1019,2016 n=677; Norway

2014 n=806,2016 n=632; Saudi Arabia 2016 n=544; Singapore 2014 n=806,2016 n=597; US 2014 n=2011,2016 n=1654;

Q845. (Q160.) Which of the following data in electronic health records do you have access to?


EHR Data Have Access To

Global Australia Brazil England Norway

Saudi

Arabia Singapore US

2016 2014 2016 2014 2016 2014 2016 2014 2016 2016 2014 2016 2014 2016

Lab work and

blood test

results 35% 7% 19% 42% 43% 7% 13% 13% 22% 48% 16% 34% 24% 48%

Prescription

medication

history32% 10% 18% 26% 33% 10% 22% 15% 25% 35% 16% 33% 23% 44%

Personal

profile

information26% 8% 11% 15% 27% 7% 11% 7% 17% 36% 16% 33% 15% 36%

Physician

notes from

visits or

about my

medical

condition

26% 8% 14% 20% 25% 7% 13% 14% 23% 40% 14% 31% 15% 33%

Immunization

status25% 7% 13% 12% 17% 6% 12% 13% 20% 30% 8% 26% 16% 37%

X-rays or

nuclear

imaging

results

26% 8% 19% 28% 30% 5% 11% 12% 21% 38% 15% 34% 13% 29%

Billing

information24% 9% 14% 16% 17% 4% 7% 8% 13% 33% 22% 37% 18% 35%

Other 1% 1% 1% 0% 2% 1% 1% 0% 2% 3% 1% 2% 1% 0%

Don’t know 44% 79% 66% 33% 35% 79% 62% 74% 58% 20% 56% 36% 61% 35%


Consumers access their EHR to stay informed and

satisfy curiosity

BASE: HAS ACCESSED EHR : Global 2016 n=1611;Australia 2014 n=106,2016 n=95; Brazil 2014 n=357,2016 n=214; England 2014 n=75,2016 n=89;

Norway 2014 n=89,2016 n=159; Saudi Arabia 2016 n=166; Singapore 2014 n=165,2016 n=150; US 2014 n=434,2016 n=738;

Q821. (Q169. What is the primary reason you access your electronic health records?


Primary Reason Access EHR

Global Australia Brazil England Norway Saudi

Arabia

Singapore US

2016 2014 2016 2014 2016 2014 2016 2014 2016 2016 2014 2016 2014 2016

To keep me

informed34% 37% 22% 32% 39% 37% 28% 35% 25% 23% 26% 27% 43% 41%

Curious to

know what is

in medical

record

23% 18% 24% 15% 15% 15% 26% 24% 30% 23% 15% 19% 17% 25%

Make sure

medical

record is

accurate

19% 25% 31% 17% 19% 20% 13% 21% 25% 20% 21% 21% 18% 16%

Track the

progression

of medical

illness or

disease

12% 6% 14% 24% 15% 12% 10% 8% 6% 13% 20% 22% 12% 10%

Help make

medical

decisions 9% 13% 5% 12% 11% 16% 20% 10% 8% 20% 18% 11% 9% 6%

Other 2% 2% 4% 1% 0% 0% 2% 2% 6% 1% 0% 0% 2% 2%


Lab work and blood test results in EHRs are most

helpful for managing health

BASE: KNOWS WHAT DATA HAVE ACCESS TO IN EHR, HAVE ACCESS TO MULTIPLE TYPES OF DATA: Global Total n= 2309; Australia n= 161; Brazil n= 314;

England n= 138; Norway n= 199; Saudi Arabia n= 306; Singapore n= 285; US n= 906

Q850. Which of the following types of information in your electronic health record most helps you manage your health?

EHR Data that Most Helps Manage Health


Arabia

Singapore US

Lab work and blood test

results 34% 28% 42% 14% 15% 34% 28% 41%

Physician notes from my

visits or about my

medical condition

26% 22% 23% 22% 34% 27% 34% 24%

Prescription medication

history11% 17% 13% 26% 14% 7% 10% 9%

Personal profile

information6% 5% 6% 5% 3% 11% 6% 5%

Immunization status 5% 7% 5% 3% 9% 4% 4% 5%

X-rays or nuclear imaging

results6% 4% 8% 4% 10% 6% 6% 5%

Billing information 5% 4% 2% 3% 6% 6% 7% 5%

Other 0% 0% 0% 1% 0% 0% 0% 0%

Don’t know 7% 12% 1% 22% 10% 5% 5% 6%


Consumers and doctors agree that patients should have

access to EHRs, but consumers want full access, while

doctors prefer limited access

BASE: ALL QUALIFIED RESPONDENTS: Global Total n= 7840; Australia n= 1013; Brazil n= 1006; England n= 1009; Norway n= 800; Saudi Arabia n= 852; Singapore n= 935; US n= 2225

Q830. (D905/710) What level of access should you as a patient have to your electronic health record, created by your physician?

*2015 Accenture Doctors Survey

Level of Access Patient Should Have to EHR

Any

Access 98%


84% 85% 92% 87% 87% 92%98% 99% 96% 98% 97% 97% 99%97%

2% 2%

16%

1%

15%

4% 8%2%

13%3% 5% 2%

14%

1%7%

13% 10%

73%

15%

60%

15%

70%

14%

61%

22%

73%

15%

70%

7%

74%

85% 88%

11%

84%

25%

81%

22%

84%

26%

75%

23%

82%

17%

92%

18%

No access Limited Access Full Access


71% 75%70% 72% 74%

55%66%

77%

29% 25%30% 28% 26%

45%34%

23%

2016 2016 2016 2016 2016 2016 2016 2016

Exactly what the doctor sees Summary version of what doctor sees

Consumers who want EHR access want to see exactly

what the doctor sees, not a summary version

BASE: SHOULD HAVE ACCESS TO EHR : Global Total n= 7684; Australia n= 997; Brazil n= 990; England n=981; Norway n= 787; Saudi Arabia n= 825; Singapore n= 901; US n= 2203

Q835. What information should you as a patient see in your electronic health record?

Type of Information Patient Should See in EHR



Most consumers report having at least limited access to

their EHR, although this varies greatly by country


Q840. (D905/710) What level of access do you as a patient have to your electronic health record, created by your physician?

Level of Access Patient Does Have to EHR

36%

54%49%

54%

37%

19% 21% 24%

23%

18% 27% 19%

24%

24% 18%

27%

41%

28% 23% 26%40%

57% 61%

49%

2016 2016 2016 2016 2016 2016 2016 2016

No access Limited Access Full Access

Any

Access 64%


46% 50% 45% 64% 81% 79% 76%


Consumers and doctors agree that patients should

update most information in their EHRs

BASE: ALL QUALIFIED RESPONDENTS: Global 2016 n=7840;Australia 2016 n=1013; Brazil 2016 n=1006; England 2016 n=1009; Norway 2016 n=800; Saudi Arabia

2016 n=852; Singapore 2016 n=935; US 2016 n=2225

Q880. (D910/712) How much of each of the following types of information should you, as a patient be able to update in your electronic personal health record?


Full data available in Appendix


Consumers Consumers Doctors Consumers Doctors Consumers Doctors Consumers Doctors Consumers Doctors Consumers Doctors Consumers Doctors

Demographic

Information80% 79% 94% 82% 85% 70% 91% 68% 87% 76% 92% 86% 88% 86% 95%

Personal

medical

history79% 76% 81% 82% 81% 68% 76% 73% 81% 81% 92% 87% 85% 83% 90%

Family

medical

history84% 81% 87% 84% 87% 76% 82% 73% 80% 83% 97% 90% 83% 89% 93%

New

symptoms83% 77% 79% 90% 84% 74% 70% 79% 80% 86% 41% 87% 89% 87% 83%

Change in

symptoms82% 79% 81% 88% 83% 74% 72% 75% 81% 84% 40% 86% 87% 86% 84%

New

medications73% 65% 79% 80% 84% 61% 67% 67% 73% 80% 38% 74% 85% 75% 88%

Medication

side effects84% 80% 84% 88% 86% 76% 75% 81% 79% 85% 85% 88% 83% 84% 86%

Allergic

episodes83% 80% 84% 89% 90% 74% 74% 81% 85% 83% 58% 90% 86% 86% 88%

Lab test

results63% 54% 52% 77% 73% 55% 44% 59% 56% 74% 39% 69% 71% 57% 63%

Self-

measured

metrics79% 75% 82% 84% 81% 72% 78% 73% 84% 81% 40% 89% 92% 79% 83%

Patient Should Update Some or All Information in EHR


21% 21%

6%18% 15%

30%

9%

33%

13%24%

8% 13% 12% 15%5%

33% 34%

28%

35%30%

33%

29%

36%

43%

36%

26%

33% 32% 28%

23%

47% 45%

66%

47%56%

37%

62%

32%45% 40%

66%53% 56% 58%

72%

Patient should not update Some information All information


update demographic information in EHRs


2016 n=852; Singapore 2016 n=935; US 2016 n=2225



Level of Patient Updating to Electronic Personal Health Record: Demographic information

Saudi Arabia

80%Update

Any

Global Australia Brazil England Norway Singapore US

94% 85% 91% 87% 88% 95%79% 82% 70% 68% 76% 86% 86%92%


21% 25%19% 18% 19%

32%24% 27%

19% 19%8% 13% 15% 17%

10%

28%28% 40%

25%29%

27%36% 29% 47%

30%

18%

35% 34% 26% 40%

51% 48% 41%

57% 52%41% 39% 44%

34%

51%

74%

52% 51%57%

50%



update personal medical history in EHRs

Level of Patient Updating to Electronic Personal Health Record: Personal medical history

Update

Any


BASE: ALL QUALIFIED RESPONDENTS : Global 2016 n=7840;Australia 2016 n=1013; Brazil 2016 n=1006; England 2016 n=1009; Norway 2016 n=800; Saudi Arabia

2016 n=852; Singapore 2016 n=935; US 2016 n=2225



Saudi Arabia

81% 81% 76% 81% 85% 90%79% 76% 82% 68% 73% 81% 87% 83%92%


16% 19%13% 16% 13%

25%18%

26%20% 17%

3%10%

17%10% 7%

33%33%

36% 27% 28%

35%39%

43%43%

36%

20%

38%32%

28% 29%

51% 48% 51%57% 59%

41% 43%30% 37%

47%

77%

52% 51%61% 65%



update family medical history in EHRs

Level of Patient Updating to Electronic Personal Health Record: Family medical history

Update

Any



2016 n=852; Singapore 2016 n=935; US 2016 n=2225



Saudi Arabia

87% 87% 82% 80% 83% 93%84% 81% 84% 76% 73% 83% 90% 89%97%


16%22% 21%

9%16%

26% 30%21% 20% 15%

59%

12% 11% 14% 17%

28%28%

36%

23%

26%

28%33%

30%44%

30%

14%

34% 40%27%

37%

55%49%

43%

67%58%

46%37%

49%36%

56%

27%

53%49%

60%46%



update new symptoms in EHRs

Level of Patient Updating to Electronic Personal Health Record: New symptoms

Update

Any



2016 n=852; Singapore 2016 n=935; US 2016 n=2225



Saudi Arabia

79% 84% 70% 80% 89% 83%83% 77% 90% 74% 79% 86% 87% 87%41%


18% 21% 19%12% 17%

26% 28% 25%19% 16%

60%

13% 13% 14% 16%

30%33% 38%

25%28%

31%37%

33% 44%

32%

11%

35% 36%28%

41%

52%46% 42%

63%55%

43%34%

42% 37%

52%

29%

51% 51%58%

43%



update changes in symptoms in EHRs

Level of Patient Updating to Electronic Personal Health Record: Changes in symptoms

Update

Any



2016 n=852; Singapore 2016 n=935; US 2016 n=2225



Saudi Arabia

81% 83% 72% 81% 87% 84%82% 79% 88% 74% 75% 84% 86% 86%40%


28%35%

21% 19% 16%

39%33% 33%

27%20%

62%

26%15%

25%12%

25%22%

30%24% 27%

22%27% 25%

27%30%

11%

28%

24%

24%

31%

48% 43%49%

56% 56%

39% 40% 42% 47% 50%

27%

46%

60%51%

57%



update new medications in EHRs

Level of Patient Updating to Electronic Personal Health Record: New medications

Update

Any



2016 n=852; Singapore 2016 n=935; US 2016 n=2225



Saudi Arabia

79% 84% 67% 85% 88%73%73% 65% 80% 61% 67% 80% 74% 75%38%


17% 20% 16% 12% 14%24% 25% 20% 21%

15% 15% 12% 17% 16% 14%

29%30% 36%

23%26%

30% 32%30%

45%

31%

16%33% 28% 26%

37%

55% 50% 49%

65%61%

46% 43%51%

34%

54%

69%55% 55% 58%

49%



update medication side effects in EHRs

Level of Patient Updating to Electronic Personal Health Record: Medication side effects

Update

Any



2016 n=852; Singapore 2016 n=935; US 2016 n=2225



Saudi Arabia

84% 86% 75% 79% 83% 86%84% 80% 88% 76% 81% 85% 88% 84%85%


16% 20% 16% 11% 10%

26% 26%20% 15% 17%

42%

10% 14% 14% 12%

29%31%

29%25% 23%

29% 28%33%

34% 30%

10%

34% 31% 27% 35%

54%49%

55%64% 68%

45% 46% 48% 51% 53% 47%56% 55% 59%

53%



update allergic episodes in EHRs

Level of Patient Updating to Electronic Personal Health Record: Allergic episodes

Update

Any



2016 n=852; Singapore 2016 n=935; US 2016 n=2225



Saudi Arabia

84% 90% 74% 85% 86% 88%83% 80% 89% 74% 81% 83% 90% 86%58%


38%46% 48%

23% 27%

45%56%

41% 44%

26%

61%

32% 29%42% 37%

19%

18%28%

18%21%

19%

23%

18%

29%

24%

10%

24% 33%15% 30%

44%36%

24%

59%52%

36%

22%

41%27%

50%

29%45% 38%

42%33%


Many consumers and doctors say that patients should

update lab test results in EHRs, but with some more

resistance from doctors than on other types of information

Level of Patient Updating to Electronic Personal Health Record: Lab test results

Update

Any



2016 n=852; Singapore 2016 n=935; US 2016 n=2225



Saudi Arabia

52% 73% 44% 56% 71% 63%63% 54% 77% 55% 59% 74% 69% 57%39%


21% 25%18% 16% 19%

28%22% 27%

16% 19%

60%

11% 8%21% 17%

30%30% 39%

26%30%

30% 37% 32%44%

27%

12%

36% 40%

29% 36%

49% 45% 43%

58%51%

42% 41% 41% 40%54%

28%

53% 52% 50% 46%



update self-measured metrics in EHRs

Level of Patient Updating to Electronic Personal Health Record: Self-measured metrics

Update

Any



2016 n=852; Singapore 2016 n=935; US 2016 n=2225



Saudi Arabia

82% 81% 78% 84% 92% 83%79% 75% 84% 72% 73% 81% 89% 79%40%


Consumers see EHRs as tools for their doctors and

themselves, not to be shared with others (i.e.,

government, employers)


Q825. Who should have access to your electronic health records?

Who should have access to your EHR?


Arabia

Singapore US

My primary doctor 69% 79% 65% 71% 80% 51% 57% 75%

Me 60% 63% 63% 56% 61% 47% 50% 67%

Hospitals I visit 52% 59% 40% 59% 67% 42% 48% 51%

Other doctors or

specialists 49% 56% 46% 50% 51% 40% 35% 55%

Anyone I give permission

to41% 47% 30% 35% 34% 27% 45% 52%

Urgent care centers I visit 32% 35% 33% 32% 44% 24% 23% 32%

A doctor performing a

procedure in another

country

29% 37% 31% 31% 30% 19% 22% 30%

My pharmacy 22% 24% 13% 22% 19% 23% 13% 28%

Family members 20% 16% 30% 10% 9% 22% 30% 22%

Caregiver 15% 15% 14% 10% 8% 17% 15% 20%

Retail clinics I visit 13% 10% 35% 6% 4% 8% 19% 9%

An overseas health

expert performing clinical

analysis

13% 15% 20% 11% 11% 18% 13% 8%

The government 6% 5% 4% 3% 2% 16% 12% 3%

My employer 4% 1% 7% 3% 3% 8% 5% 3%


Consumers using technology to manage their health

rely on websites in particular; in some countries use of

apps and wearables is up from 2014

BASE: USES TECHNOLOGY TO MANAGE HEALTH: Global 2016 n=5130;Australia 2014 n=1011,2016 n=551; Brazil 2014 n=894,2016 n=916;

England 2014 n=1013,2016 n=466; Norway 2014 n=380,2016 n=421; Saudi Arabia 2016 n=680; Singapore 2014 n=567,2016 n=662; US 2014 n=1605,2016 n=1434

Q625. (Q126.) Which of the following technology or electronic health management tools have you used to manage your health in the past year?


Technology or Electronic Health Management Tools Used (Past Year)


Arabia

Singapore US

2016 2014 2016 2014 2016 2014 2016 2014 2016 2016 2014 2016 2014 2016

Websites 52% 50% 50% 58% 62% 45% 44% 57% 40% 44% 61% 50% 55% 57%

Mobile

phone/tablet

app36% 15% 29% 30% 37% 13% 36% 33% 30% 40% 40% 44% 16% 33%

Social media 27% 11% 17% 29% 40% 9% 21% 22% 22% 41% 29% 26% 14% 21%

Wearable

technology19% 6% 21% 29% 15% 6% 20% 15% 19% 14% 17% 23% 9% 21%

Smart scales 19% 10% 14% 34% 30% 10% 14% 14% 11% 25% 27% 19% 10% 13%

EHRs 19% 20% 13% 56% 20% 17% 12% 30% 15% 16% 40% 18% 32% 27%

Online

support

communities16% 8% 11% 18% 22% 10% 17% 11% 11% 16% 17% 18% 10% 12%

Remote

consultation 15% 5% 8% 19% 21% 10% 10% 18% 16% 24% 8% 10% 12% 12%

Remote

monitoring*10% N/A 5% N/A 16% N/A 6% N/A 8% 12% N/A 10% N/A 8%

Other 2% 3% 2% 2% 2% 2% 2% 3% 4% 1% 1% 1% 2% 2%

None 10% 34% 17% 3% 8% 32% 12% 8% 17% 6% 4% 7% 22% 10%

*Added in 2016


Fitness and diet/nutrition apps are the most popular

among health app users

BASE: USED APPS IN PAST YEAR TO MANAGE HEALTH: Global Total n= 1824; Australia n= 160; Brazil n= 337; England n= 166; Norway n= 125; Saudi Arabia n= 271; Singapore n= 291; US n= 474

Q630. What type of app(s) have you used?

Type of App(s) Used


Arabia

Singapore US

Fitness 55% 66% 55% 52% 39% 46% 54% 59%

Diet/Nutrition 53% 48% 68% 44% 52% 54% 42% 52%

Symptom navigator 24% 18% 25% 8% 11% 24% 20% 36%

Health or condition tracker 24% 20% 27% 21% 18% 28% 25% 25%

Patient portal app 22% 15% 32% 15% 22% 19% 12% 28%

Medication

tracker/reminder/manager 18% 15% 33% 12% 19% 18% 16% 12%

Chronic condition or

disease management 11% 10% 14% 9% 15% 17% 7% 10%

Something else 9% 12% 4% 13% 15% 10% 14% 6%


Consumers and doctors in Australia agree

that wearable health devices help patient engagement

22%

25%

27%

28%

22%

28%

46%

24%

3%

4%

4%

5%

3%

4%

5%

4%

75%

70%

68%

67%

75%

67%

49%

72%

Engagement with own health

Accuracy of medical record

Patient/physician communication

Patient satisfaction

Understanding of health condition

Overall quality of care

Reduction in cost of healthcare

Monitoring the health of a loved one

13%

33%

34%

19%

21%

29%

46%

1%

3%

5%

2%

2%

2%

19%

86%

64%

61%

79%

77%

69%

35%

Effect of Wearables On…

Consumer Perspective Doctor* Perspective

Has no effect Hurts Helps

BASE: ALL QUALIFIED RESPONDENTS (2016 n=1013)

Q660 (D1070) Do you think the use of wearable health devices (for monitoring glucose, heart rate, physical activity, sleep, or weight) helps, hurts or has no effect on …?


N/A


Consumers and doctors in Brazil agree


7%

14%

12%

12%

8%

15%

25%

9%

6%

6%

8%

5%

7%

7%

10%

5%

87%

79%

80%

83%

85%

78%

65%

85%









3%

19%

16%

12%

11%

16%

34%

3%

6%

5%

4%

4%

5%

20%

94%

75%

79%

84%

85%

79%

46%







N/A


Consumers and doctors in England agree


28%

34%

32%

38%

27%

37%

51%

31%

7%

7%

6%

8%

8%

6%

7%

7%

65%

60%

62%

55%

65%

56%

41%

62%









12%

30%

38%

19%

22%

33%

44%

2%

8%

9%

4%

6%

4%

25%

86%

62%

53%

77%

72%

63%

31%







N/A


Consumers and doctors in Norway agree


33%

40%

37%

41%

31%

43%

55%

49%

7%

7%

10%

9%

8%

8%

9%

6%

60%

53%

53%

50%

61%

49%

36%

45%









26%

35%

38%

24%

24%

39%

56%

4%

5%

5%

5%

3%

2%

18%

70%

60%

57%

71%

73%

59%

26%







N/A


Consumers and doctors in Saudi Arabia agree that

wearable health devices help patient engagement

18%

24%

18%

24%

12%

19%

24%

18%

8%

6%

6%

5%

6%

7%

12%

7%

74%

71%

76%

71%

83%

73%

64%

74%










Consumer Perspective





5%

5%

6%

5%

6%

4%

1%

11%

6%

8%

13%

7%

6%

14%

84%

89%

87%

82%

87%

90%

85%

Doctor* Perspective


Consumers and doctors in Singapore agree that

wearable health devices help patient engagement

16%

23%

26%

32%

12%

23%

33%

14%

6%

6%

6%

6%

5%

7%

12%

5%

78%

72%

68%

62%

82%

71%

56%

81%









11%

40%

35%

22%

27%

33%

43%

8%

8%

8%

5%

7%

5%

21%

81%

63%

67%

72%

76%

73%

39%







N/A


Consumers and doctors in the US agree


19%

29%

26%

31%

20%

29%

41%

22%

4%

4%

5%

4%

4%

4%

8%

4%

77%

67%

69%

64%

76%

67%

51%

74%









12%

40%

35%

22%

27%

33%

43%

3%

8%

8%

5%

7%

5%

21%

85%

52%

57%

73%

66%

62%

36%







N/A


Many consumers wear or would be willing to wear

health tracking technology

BASE: ALL QUALIFIED RESPONDENTS: Global 2016 n=7840;Australia 2014 n=1020,2016 n=1013; Brazil 2014 n=1015,2016 n=1006; England 2014 n=1019,2016 n=1009;

Norway 2014 n=806,2016 n=800; Saudi Arabia 2016 n=852; Singapore 2014 n=806,2016 n=935; US 2014 n=2011,2016 n=2225

Q645. (Q151). Do you or would you be willing to wear technology that measures and tracks…?



Arabia

Singapore US

2016 2014 2016 2014 2016 2014 2016 2014 2016 2016 2014 2016 2014 2016

Fitness and

lifestyle only 17% 11% 15% 26% 19% 12% 14% 19% 16% 24% 18% 18% 11% 15%

Vital signs

only 16% 12% 11% 18% 20% 15% 15% 18% 19% 23% 20% 16% 15% 12%

Both 45% 56% 49% 51% 55% 54% 44% 36% 27% 31% 49% 48% 50% 51%

Neither 22% 21% 25% 5% 6% 18% 27% 27% 38% 21% 13% 19% 24% 21%

Wears or Would Be Willing to Wear Technology to Track…


Some app users have discussed or shared app data

with their doctors (particularly in Brazil)

BASE: USED APPS IN PAST YEAR TO MANAGE HEALTH: Global Total n= 1824; Australia n= 160; Brazil n= 337; England n= 166; Norway n= 125; Saudi Arabia n= 271; Singapore n= 291; US n= 474

Q635. Have you discussed or shared data from your app with your doctor or other medical provider?

Discussed or Shared app Data with Doctor

60%70%

37%

84%

71%

57%

70%60%

40%30%

63%

16%

29%

43%

30%40%

2015 2015 2015 2015 2015 2015 2015 2015

No Yes



Across all countries, fewer than half of consumers

report that a doctor recommended wearable technology

to track health

BASE: ALL QUALIFIED RESPONDENTS: Global 2016 n=7840;Australia 2016 n=1013; Brazil 2016 n=1006; England 2016 n=1009; Norway 2016 n=800;

Saudi Arabia 2016 n=852; Singapore 2016 n=935; US 2016 n=2225

Q650. Has a doctor ever recommended that you wear technology to measure and track the following?

Doctor Has Recommended Wearable Technology to Track…

24%

16%

47%

19%24%

31%

22%19%

23%

16%

43%

15%20%

37%

22%18%

2016 2016 2016 2016 2016 2016 2016 2016

Vital signs Fitness and lifestyle



Among consumers whose doctor recommended

wearable technology, the majority took their doctor’s

advice

BASE: DOCTOR RECOMMENDED WEARABLE: Global Total n= 2279; Australia n= 217; Brazil n= 524; England n= 224; Norway n= 208; Saudi Arabia n= 372; Singapore n= 225; US n= 461

Q655. Did you take your doctor’s advice to wear technology to measure and track your fitness and lifestyle or vital signs?

Took Doctor’s Advice to Use Wearable Technology

23%34%

13%

26%20%

26% 30%24%

77%66%

87%

74%80%

74% 70%76%

2016 2016 2016 2016 2016 2016 2016 2016

No Yes



The majority of consumers are willing to share wearable

and app data with their doctors…

Willingness to Share Wearable or Mobile App Data With…

Your doctor

Willing

6% 5% 4%9% 11% 7% 3% 5%

8% 6% 7%7%

12% 17%

10% 5%

35%31%

37%34%

31%35%

51%

29%

51%58%

52% 50% 45%40%

35%

60%

2016 2016 2016 2016 2016 2016 2016 2016

Not at all willing Not very willing Somewhat willing Very willing


85% 89% 89% 84% 76% 76% 87% 90%

BASE: ALL QUALIFIED RESPONDENTS: Global 2016 n=7840;Australia 2016 n=1013; Brazil 2016 n=1006; England 2016 n=1009; Norway 2016 n=800; Saudi Arabia 2016

n=852; Singapore 2016 n=935; US 2016 n=2225

Q670. How willing would you be to share information from your wearable technology or mobile app (e.g., activity throughout the day, heart rate) with each of the following?


…their nurses or other healthcare professionals


Your nurse or other healthcare professional

Willing

8% 9% 6% 10%16%

10%4% 7%

12% 10% 14%11%

17%23%

15% 6%

43%40%

47%40%

39% 42%

57%

39%

37% 41%33%

39%28% 24% 25%

48%

2016 2016 2016 2016 2016 2016 2016 2016




n=852; Singapore 2016 n=935; US 2016 n=2225


80% 81% 80% 79% 67% 67% 82% 87%


21%28%

10%

37% 33%

13% 12%18%

23%

26%

19%

23%24%

25%33% 18%

38%

36%

44%

30%31%

39%

45%

40%

18%11%

27%

11% 12%23%

10%

23%

2016 2016 2016 2016 2016 2016 2016 2016


Many consumers are willing to share wearable or app

data with their health insurance plan, more so in certain

countries (i.e., Brazil)


n=852; Singapore 2016 n=935; US 2016 n=2225



Your health insurance plan

56%Willing


47% 71% 40% 43% 62% 55% 63%


13% 13%8%

19% 23%12%

5%13%

17% 17%

12%

19%

26%

21%

17%

15%

43% 45%

42%

40%

35%

43%

53% 41%

26% 25%

37%

22%16%

24% 25%30%

2016 2016 2016 2016 2016 2016 2016 2016


Consumers are willing to share wearable and app data

with friends or family members


Friend or family member

Willing



n=852; Singapore 2016 n=935; US 2016 n=2225


69% 70% 79% 62% 51% 67% 78% 72%


35%41%

17%

47%54%

19% 21%

39%

27%

29%

23%

26%

24%

31%

41%

23%

28%23%

37%

21%17%

37%

32%27%

11% 7%

24%

6% 4%13%

6%11%

2016 2016 2016 2016 2016 2016 2016 2016



Online community/other app users

Willing



n=852; Singapore 2016 n=935; US 2016 n=2225


38% 30% 61% 27% 22% 50% 38% 38%

Most consumers are hesitant to share data with other

app users or online community members


37%47%

19%

46% 49%

23% 21%

43%

29%

30%

27%

27%27%

33% 40%

26%

24%

16%

37%

18%17%

32%32%

21%

10% 7%17%

8% 8%11%

7% 10%

2016 2016 2016 2016 2016 2016 2016 2016


Consumers are not willing to share wearable and app

data with their employers


Your employer

Willing



n=852; Singapore 2016 n=935; US 2016 n=2225


34% 22% 54% 26% 24% 44% 38% 31%


Consumers and doctors in Australia associate

virtual visits with convenience and lower costs,

but in-person visits with quality care

Advantages of Virtual or In-Person Visits: Australia

Percent Ranking Top 3 for In-Person and Virtual

Doctors*Consumers

69%

51%

50%

29%

28%

19%

19%

16%

11%

30%

19%

35%

28%

46%

41%

60%

Providing quality care to patients

Diagnosing problems faster

Engaging patients in theirhealth/healthcare decisions

Providing timely care to patients

Reducing potential (or number of)adverse events

Accommodating patients' schedules

Accommodating physicians' schedules

Reducing medical costs to patients

In-Person Virtual

BASE: ALL QUALIFIED RESPONDENTS (n=1013)

Q760. (D1035) From the list below, please select the top three advantages of in-person patient visits and the top three advantages of remote or virtual visits.


82%

56%

54%

42%

27%

24%

5%

5%

8%

11%

20%

9%

31%

52%

80%

72%



Engaging patients in decisions

Reducing adverse events

Accommodating physicians'schedule


Accommodating patients'schedules

Reducing medical costs topatients

In-Person Virtual


Consumers and doctors in Brazil associate



Advantages of Virtual or In-Person Visits: Brazil


Doctors*Consumers

68%

59%

44%

37%

18%

16%

15%

14%

10%

13%

31%

20%

42%

54%

50%

54%


Engaging patients in their health/healthcaredecisions


Reducing potential (or number of) adverseevents





In-Person Virtual

BASE: ALL QUALIFIED RESPONDENTS BASE: ALL QUALIFIED RESPONDENTS (n=1006)



88%

59%

54%

53%

17%

11%

6%

5%

4%

12%

12%

17%

42%

66%

73%

63%









In-Person Virtual


Doctors in England are more likely to see

reducing adverse events as a top advantage of

in-person visits vs. patients

Advantages of Virtual or In-Person Visits: England


Doctors*Consumers

61%

49%

46%

35%

26%

20%

20%

15%

13%

30%

22%

30%

30%

41%

50%

46%









In-Person Virtual

BASE: ALL QUALIFIED RESPONDENTS (n=1009)



83%

63%

53%

46%

27%

14%

5%

3%

5%

15%

20%

7%

43%

54%

81%

59%









In-Person Virtual


Although consumers and doctors in Norway associate

virtual visits with scheduling convenience, many see

timely care as an advantage of in-person visits

Advantages of Virtual or In-Person Visits: Norway


Doctors*Consumers

67%

49%

39%

37%

33%

19%

16%

10%

10%

32%

25%

28%

18%

39%

50%

58%









In-Person Virtual

BASE: BASE: ALL QUALIFIED RESPONDENTS (n=800)



83%

69%

39%

36%

33%

24%

3%

3%

3%

14%

32%

26%

10%

38%

80%

79%









In-Person Virtual


Consumers and doctors in Saudi Arabia associate

in-person visits with quality care; consumers see

virtual as cost-effective

Advantages of Virtual or In-Person Visits: Saudi Arabia


Consumers

48%

47%

36%

33%

32%

25%

25%

23%

21%

26%

28%

33%

29%

37%

37%

50%









In-Person Virtual




55%

43%

41%

35%

32%

29%

25%

22%

22%

35%

23%

33%

33%

51%

34%

47%









In-Person Virtual

Doctors*


Consumers and doctors in Singapore associate

virtual visits with convenience and lower costs, but in-

person visits with quality care and patient engagement

Advantages of Virtual or In-Person Visits: Singapore


Doctors*Consumers

64%

55%

53%

29%

28%

19%

16%

16%

13%

23%

19%

22%

41%

40%

56%

58%









In-Person Virtual




62%

61%

46%

43%

32%

26%

15%

14%

14%

21%

21%

23%

38%

40%

67%

68%









In-Person Virtual


Consumers and doctors in the US associate






Advantages of Virtual or In-Person Visits: US


81%

54%

50%

43%

30%

22%

8%

7%

7%

15%

20%

12%

37%

49%

80%

62%





Accommodating physicians' schedule




In-Person Virtual

Doctors*Consumers

68%

50%

48%

32%

25%

21%

18%

15%

11%

17%

29%

20%

42%

41%

52%

58%









In-Person Virtual


Overall, the majority of consumers continue to prefer in-

person visits over remote

BASE: ALL QUALIFIED RESPONDENTS: Global 2016 n=7840;Australia 2014 n=1020,2016 n=1013; Brazil 2014 n=1015,2016 n=1006; England 2014

n=1019,2016 n=1009; Norway 2014 n=806,2016 n=800; Saudi Arabia 2016 n=852; Singapore 2014 n=806,2016 n=935; US 2014 n=2011,2016 n=2225

Q750. (Q199). Which of the following is closer to your view?


Prefer Remote or In-Person Visits

29%

14%18%

30%

42%

24% 24%20% 23%

35% 33%28%

23%29%

71%

86%82%

70%

58%

76% 76%80% 77%

65% 67%72%

77%71%

2016 2014 2016 2014 2016 2014 2016 2014 2016 2016 2014 2016 2014 2016

Remote In-person


Accenture 2016 Consumer Survey on Patient …...Title Accenture 2016 Consumer Survey on Patient...

Documents

Transcript of Accenture 2016 Consumer Survey on Patient …...Title Accenture 2016 Consumer Survey on Patient...